Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Molecular epidemiology of Shigella flexneri in a diarrhoea-endemic area of Lima, Peru.

Fernandez-Prada CM, Venkatesan MM, Franco AA, Lanata CF, Sack RB, Hartman AB, Spira W.

Epidemiol Infect. 2004 Apr;132(2):303-16.

2.

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

Katz DE, Coster TS, Wolf MK, Trespalacios FC, Cohen D, Robins G, Hartman AB, Venkatesan MM, Taylor DN, Hale TL.

Infect Immun. 2004 Feb;72(2):923-30.

3.
4.

Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.

Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, McDonough M, Butterton J.

Infect Immun. 2002 Jun;70(6):2950-8.

5.
6.

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

Turbyfill KR, Hartman AB, Oaks EV.

Infect Immun. 2000 Dec;68(12):6624-32.

7.

Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages.

Fernandez-Prada CM, Hoover DL, Tall BD, Hartman AB, Kopelowitz J, Venkatesan MM.

Infect Immun. 2000 Jun;68(6):3608-19.

9.

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.

Coster TS, Hoge CW, VanDeVerg LL, Hartman AB, Oaks EV, Venkatesan MM, Cohen D, Robin G, Fontaine-Thompson A, Sansonetti PJ, Hale TL.

Infect Immun. 1999 Jul;67(7):3437-43.

11.

Identification and molecular characterization of a 27 kDa Shigella flexneri invasion plasmid antigen, IpaJ.

Buysse JM, Dunyak DS, Hartman AB, Venkatesan MM.

Microb Pathog. 1997 Dec;23(6):357-69.

PMID:
9441862
12.

Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models.

Van De Verg LL, Hartman AB, Bhattacharjee AK, Tall BD, Yuan L, Sasala K, Hadfield TL, Zollinger WD, Hoover DL, Warren RL.

Infect Immun. 1996 Dec;64(12):5263-8.

13.

Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a.

Hartman AB, Van de Verg LL, Mainhart CR, Tall BD, Smith-Gill SJ.

Clin Diagn Lab Immunol. 1996 Sep;3(5):584-9.

14.

Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.

Van De Verg LL, Bendiuk NO, Kotloff K, Marsh MM, Ruckert JL, Puryear JL, Taylor DN, Hartman AB.

Vaccine. 1996 Aug;14(11):1062-8.

PMID:
8879103
15.

Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.

Alexander WA, Hartman AB, Oaks EV, Venkatesan MM.

Vaccine. 1996 Aug;14(11):1053-61.

PMID:
8879102
16.

Genetic polymorphism of the ipaH multicopy antigen gene in Shigella spps. and enteroinvasive Escherichia coli.

Buysse JM, Hartman AB, Strockbine N, Venkatesan M.

Microb Pathog. 1995 Nov;19(5):335-49.

PMID:
8778567
17.

Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Hartman AB, Van de Verg LL, Collins HH Jr, Tang DB, Bendiuk NO, Taylor DN, Powell CJ.

Infect Immun. 1994 Feb;62(2):412-20.

18.

Sequences of four new members of the VH7183 gene family in BALB/c mice.

Chukwuocha RU, Hartman AB, Feeney AJ.

Immunogenetics. 1994;40(1):76-8. No abstract available.

PMID:
8206530
19.

Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.

Hartman AB, Powell CJ, Schultz CL, Oaks EV, Eckels KH.

Infect Immun. 1991 Nov;59(11):4075-83.

20.

Sequence variation in two ipaH genes of Shigella flexneri 5 and homology to the LRG-like family of proteins.

Venkatesan MM, Buysse JM, Hartman AB.

Mol Microbiol. 1991 Oct;5(10):2435-45.

PMID:
1791758
21.
22.

Sequence and molecular characterization of a multicopy invasion plasmid antigen gene, ipaH, of Shigella flexneri.

Hartman AB, Venkatesan M, Oaks EV, Buysse JM.

J Bacteriol. 1990 Apr;172(4):1905-15.

23.

Direct quantitative in situ hybridization studies of Ig VH utilization. A comparison between unstimulated B cells from autoimmune and normal mice.

Kastner DL, McIntyre TM, Mallett CP, Hartman AB, Steinberg AD.

J Immunol. 1989 Oct 15;143(8):2761-7.

PMID:
2507638
24.

Organ reactive autoantibodies from non-immunized adult BALB/c mice are polyreactive and express non-biased VH gene usage.

Hartman AB, Mallett CP, Srinivasappa J, Prabhakar BS, Notkins AL, Smith-Gill SJ.

Mol Immunol. 1989 Apr;26(4):359-70.

PMID:
2497339
25.
26.

Unusual joining sites in the H and L chains of an anti-lysozyme antibody.

Hartman AB, Mallett CP, Sheriff S, Smith-Gill SJ.

J Immunol. 1988 Aug 1;141(3):932-6.

PMID:
3135317
27.

VH family usage and binding analyses of polyreactive monoclonal autoantibodies derived from nonimmunized adult BALB/c mice.

Hartman AB, Mallett CP, Srinivasappa J, Prabhakar BS, Notkins AL, Smith-Gill SJ.

Curr Top Microbiol Immunol. 1988;137:211-5. No abstract available.

PMID:
3138074
28.

The X-24 VH gene family in inbred mouse strains and wild mice.

Hartman AB, D'Hoostelaere LA, Potter M, Rudikoff S.

Curr Top Microbiol Immunol. 1986;127:157-66. No abstract available.

PMID:
2426040
29.

Supplemental Content

Loading ...
Support Center